top of page

Patch Testing and Allergy Screening Before Korean Skin Treatments: What It Covers and What It Does Not - A Complete Guide

6 days ago
12 min read
A clinician writing a patient's history onto a chart at a clinic desk

Allergy screening before a cosmetic skin treatment in Korea is almost always a history-taking exercise, not a laboratory test. Photo: Vitaly Gariev / Unsplash

Quick answer Patch testing is a diagnostic test for delayed contact allergy, not a routine safety screen before a laser or chemical peel. Korean skin clinics screen with a medical history and physical exam instead. Patch testing becomes relevant only when you already have a rash that keeps coming back.

In this guide

Most people arriving in Seoul for a laser course, a peel or an injectable assume there is a test that clears them for treatment in advance. There usually is not. The screening that happens is a conversation and an examination, and the one allergy test that does exist - patch testing - answers a different question entirely. This guide separates the two, using what Korean dermatology departments have actually published about their own patch test populations, and says plainly where the published evidence stops.

What patch testing actually is - and what it is not

Patch testing identifies delayed-type contact allergy: the kind of reaction that shows up a day or two after something touches the skin, rather than within minutes. Standardised allergen preparations are taped to the back and left in place, then read on a schedule. In the Korean studies below, one centre applied the 25-allergen Korean standard series for 48 hours and read it on days 2 and 4 [1]; another applied the same 25-material series in Finn chambers for two to three days, took a first reading 20 minutes after removal and a second reading two to three days later [2].

The question it answers is retrospective: which substance caused this rash? It is not a forecast of how your skin will respond to an energy device, an acid peel or an injectable. Nothing in either Korean series was designed to predict treatment tolerance, and neither paper claims it. If you are deciding between devices or protocols, that is a clinical and anatomical judgement, not an allergy question - we cover how Korean clinics make it in our guide to single device versus combination protocols.

What Korean clinics actually screen before a laser or peel

The published professional guidance is consistent and modest. The American Society for Dermatologic Surgery states that before laser or light therapy an ASDS doctor "will usually review the patient's medical history and conduct a physical exam", and that this is when doctor and patient discuss expectations, risks and outcomes [5]. For chemical peels the same society says only that "a thorough evaluation by a dermatologic surgeon is imperative before embarking upon a chemical peel" [6]. The American Society of Plastic Surgeons lists what a peel consultation should cover: medical conditions, drug allergies, medical treatments and smoking history, along with current medications, supplements and previous procedures [7]. Drug allergies appear as something to discuss. No society page we could verify describes allergy testing as a pre-treatment step.

The exclusions these bodies do publish are mostly about wound healing and pigment, not allergy. The ASDS lists patients who are not good candidates for laser or light therapy as those taking or recently taking isotretinoin, subject to keloid scarring, with severe or unusual scar formation, pregnant, recently tanned or sunburned, with active acne, dark skinned, on blood thinners, or with skin resurfacing disorders [5]. It also asks patients to avoid sunbathing, tanning beds, waxing, chemical peels and collagen injections for two weeks beforehand, and to avoid aspirin, anti-inflammatory drugs and herbal supplements because of bleeding risk [5]. For peels, the ASDS risk list flags pigment change as more likely in women on birth control pills, those who become pregnant, or with a history of brownish facial discoloration, plus scarring and reactivation of cold sores [6].

In practice this means the quality of your screening depends on who takes the history and whether they can take it in a language you both command. Two related questions are worth settling at the same visit: who will actually operate the device, and who is permitted to interpret what you are consenting to.

Cosmetic product bottles with printed ingredient labels on a wooden surface

A negative patch test covers the allergens on the panel, not every ingredient in the products you use. Photo: Nora Topicals / Unsplash

What the Korean patch test data shows

Two single-centre Korean series give a concrete picture of what turns up positive when patch testing is actually performed. Both used the 25-allergen Korean standard series, which makes them unusually comparable - and the comparison is instructive.

Allergen

Ewha, non-AD (n=462)

Ewha, AD history (n=53)

Dongguk, 2019-2020 (n=309)

Dongguk, 2020-2022 (n=283)

Nickel sulfate

38.1%

26.4%

48.1%

51.6%

Cobalt chloride

27.5%

24.5%

36.8%

43.8%

Potassium dichromate

13.9%

9.4%

not reported

not reported

Balsam of Peru

11.0%

not reported

21.9%

24.0%

IPPD (rubber chemical)

not reported

not reported

3.5%

7.8%

At least one positive

72.9%

56.6%

80.0%

81.0%

Ewha figures are from 515 patch tests performed between March 2017 and March 2021 [1]; Dongguk figures are from 592 patients with facial dermatoses tested between January 2019 and September 2022, split before and after mask mandates [2]. Metals dominate both. But note the spread: the same allergen, the same panel, two Korean university hospitals, and nickel differs by roughly ten percentage points. There is no single "Korean positivity rate" to quote, and anyone offering you one is reading more into these numbers than they contain.

The more important caveat is who was tested. Every patient in both series was referred because contact dermatitis was already suspected. These are not travellers booking a laser course; they are people with a rash. A 72.9% or 81.0% positive rate describes a referral clinic, not a population.

When patch testing is worth asking for

The evidence supports a narrow set of situations. Patch testing earns its place when a rash is recurring and its cause is unknown - facial dermatitis that returns after cosmetics, a reaction that reappears with each treatment course, or a topical medication that seems to be making things worse rather than better.

That last case has specific Korean support. In the Ewha series, patients with a current or past history of atopic dermatitis showed lower overall allergen positivity than those without it - 56.6% versus 72.9%, p=0.013 - yet a significantly higher rate of positivity to budesonide, a topical corticosteroid, at p=0.011 [1]. On multivariable analysis a history of atopic dermatitis carried an adjusted odds ratio of 12.1 for budesonide positivity, though with a very wide confidence interval of 1.76 to 90.22 [1]. The practical reading: if you have an atopic history and a prescribed steroid cream stops helping or aggravates the area, corticosteroid contact allergy is worth investigating rather than assuming the dose is wrong.

The mask-era data makes a second point. Positivity to IPPD, a rubber additive, roughly doubled from 3.5% to 7.8% after mask use became mandatory in Korea in October 2020, a statistically significant change at p<0.05, while overall positivity barely moved [2]. What touches your face changes, and the allergen profile follows it. A patch test is a snapshot of current exposures, not a permanent record.

Before you consent, confirm these in writing

Whether any allergy test is being proposed, what it tests for, and what a negative result would and would not rule out.

Who takes your medical history, and in which language, since drug allergies are disclosed verbally.

Whether a prior reaction to a cream, cosmetic or adhesive is recorded in your chart before treatment begins.

That the clinic is registered to treat foreign patients, which also means it carries malpractice liability insurance.

This article is general information about how screening works, not medical advice about your own skin.

The gap between the test panel and what is on your skin

A standard panel is a fixed list, and the products on a shelf are not. One Korean survey compared the ingredients of 55 cosmetics marketed in Korea against the antigens in the widely used cosmetic patch test series. It found 155 constituents across those products, of which 74 - 47.7% - were known antigens. Only 20 of those 74, or 27.0%, were included in the cosmetic series. Running the comparison the other way, only 41.7% of the 48 antigens in the series were actually present in the products surveyed. Fragrances, vehicles and surfactants were largely missing from the panel [4].

This study was published in 2010. Treat it as dated - cosmetic formulations and panel composition have both moved in sixteen years, and the specific percentages need re-checking against current data before anyone relies on them. The structural point it makes, however, is not time-sensitive: a negative patch test tells you about the allergens on the panel and nothing about the ones that were never applied. It does not clear a product.

It is also worth separating patch testing from the blood test many patients have had instead. A review of 5,760 adult dermatology patients at a Korean tertiary hospital between January 2011 and April 2020 used a multiple allergosorbent chemiluminescent assay measuring specific IgE. Allergic contact dermatitis accounted for 9.9% of diagnoses in that group, and the most prevalent allergens across the decade were house dust mites and house dust [3] - inhalant allergens. That test measures immediate-type sensitisation. It cannot identify a contact allergen, and a clean result on it says nothing about a reaction to an adhesive, a preservative or a steroid cream.

Timing, visits and why the test rarely fits a short trip

We could not verify published Korean pricing for patch testing from a primary source, so we are not quoting a figure. What the protocols do fix is the calendar. The Ewha series applied patches for 48 hours and read them on days 2 and 4 [1]; the Dongguk series patched for two to three days, read 20 minutes after removal, then read again two to three days later [2]. Either way the test spans roughly four to seven days and requires at least three separate clinic attendances, with the patches kept dry in between.

That does not fit a three-day trip, and it does not fit being scheduled alongside the treatment it is supposedly clearing you for. If you want patch testing, it belongs to a dermatology visit of its own, ideally in your home country where follow-up is possible. Note too that both Korean series stopped reading at day 4, and the Ewha authors flag this as a limitation: without a day-7 reading, corticosteroid positivity in the atopic group may have been underestimated [1]. If a steroid is the suspect, ask whether a late reading is included.

Separately, verify the clinic itself. Korea operates a registration system for medical institutions serving foreign patients, administered with the Korea Tourism Organization and the Korea Health Industry Development Institute. Registered institutions have been required to carry medical malpractice liability insurance since 2016, and the system listed more than 3,800 registered institutions as of August 2023 [8]. Checking the registration certificate is a one-minute step with real consequences, and it is independent of anything to do with allergy. The same logic applies to the paperwork: make sure someone qualified interprets your consent form, and that you understand how many visits you are committing to before you pay for a multi-session course.

What the research says

Patch test positivity in atopic versus non-atopic Korean patients (2023)

Design and population: a retrospective clinical record review of 515 patch test results from patients aged 2 to 85 referred to Ewha Womans University Medical Center, Seoul, between March 2017 and March 2021. Patients were split into an atopic dermatitis group (n=53) and a non-atopic group (n=462). Testing used the Korean standard series, 25 allergens, applied 48 hours and read on days 2 and 4 [1].

Results: any-allergen positivity was 56.6% in the atopic group versus 72.9% in the non-atopic group (p=0.013). Nickel sulfate, cobalt chloride and potassium dichromate were the commonest positives in both. Budesonide positivity was significantly higher in the atopic group (p=0.011; adjusted odds ratio 12.1, 95% CI 1.76-90.22), while balsam of Peru was higher in the non-atopic group (p=0.036). Polysensitisation did not differ significantly (11.3% versus 19.0%, p=0.168) [1].

Limitations named by the authors: the severity and duration of atopic dermatitis were not analysed; the atopic group may not represent atopic patients generally, since those with severe widespread disease cannot be tested on a clear back; and readings stopped at day 4, so steroid positivity may be understated.

What it means for you: an atopic history does not make you broadly more allergic - if anything the opposite in this cohort - but it does raise the specific possibility that a topical steroid is part of the problem. The wide confidence interval means the size of that effect is uncertain, not that the direction is.

Patch test results before and after mask mandates in Korea (2024)

Design and population: a retrospective analysis at Dongguk University Ilsan Hospital of patients with facial dermatoses who underwent patch testing, comparing 309 patients tested between January 2019 and September 2020 with 283 tested between October 2020 and September 2022, after mask use was mandated. Women were 72.8% and 74.2% of the two groups. The 25-material Korean standard series was applied in Finn chambers and graded to International Contact Dermatitis Research Group standards [2].

Results: IPPD positivity rose from 3.5% to 7.8% (p<0.05). Cobalt chloride moved from 36.8% to 43.8%, not statistically significant. Nickel sulfate was 48.1% then 51.6%, balsam of Peru 21.9% then 24.0%, and at least one positive allergen was found in 80.0% then 81.0% of patients [2].

Limitations named by the authors: KF94 mask materials vary between manufacturers and cannot be precisely identified, which makes causal attribution difficult; the date each individual started wearing a mask is unknown in a retrospective chart review; and a single institution may not represent the general population.

What it means for you: a patch test result reflects your exposures at the time it was taken. If what contacts your face has changed - a new mask, adhesive, headphone cushion or skincare routine - an older negative result is weaker evidence than it looks.

Cosmetic ingredients versus patch test panel content (2010)

Design and population: not a patient study. A survey of the declared ingredients of 55 cosmetics marketed in Korea, five from each of 11 regulatory categories, compared against the antigens in the Chemotechnique cosmetic series. Antigenicity was established by literature search [4].

Results: 155 constituents were identified; 74 (47.7%) were known antigens; only 20 of those (27.0%) appeared in the cosmetic series. Only 41.7% of the series' 48 antigens were present in the surveyed products. Parabens appeared in 24 products, phenoxyethanol in 18 and propylene glycol in 14 [4].

Limitations named by the authors: only 55 products were surveyed, so the findings should not be read as covering everything on the market, and a wider survey against the national regulator's database was called for. The study is also sixteen years old and its specific percentages require current verification.

What it means for you: panel coverage is partial by design. Ask which panel a clinic uses and whether your own suspect product can be tested as-is, rather than assuming a standard series covers it.

Frequently asked questions

Do Korean skin clinics patch test before a laser or peel?

Not as a routine step. The published professional guidance describes a medical history review and physical examination before laser or light therapy, and a thorough evaluation before a chemical peel [5] [6]. Patch testing is a diagnostic workup for suspected contact dermatitis, ordered when there is already a rash to explain.

Is a blood allergy test the same thing?

No. Blood tests measure specific IgE and detect immediate-type sensitisation, mostly to inhalant and food allergens - in one Korean series of 5,760 adults the most prevalent were house dust mites and house dust [3]. Patch testing detects delayed contact allergy. A negative blood panel does not rule out a reaction to a cream, preservative or adhesive.

How long does patch testing take?

Roughly four to seven days, across at least three clinic visits. Published Korean protocols apply patches for 48 hours with readings on days 2 and 4, or patch for two to three days and read again two to three days later [1] [2]. The area must stay dry throughout.

Does a negative patch test mean a product is safe for me?

No. It means the allergens on that panel did not provoke a reaction. A Korean survey found that only 27.0% of the known antigens identified in 55 marketed cosmetics were included in the cosmetic series panel [4]. Ingredients that were never applied cannot be excluded, and that 2010 figure itself needs re-checking against current formulations.

What should I tell the clinic if I have reacted to a cream before?

Describe the product, the time between application and the reaction, and where on the body it appeared, and ask that it be recorded in your chart before treatment. Drug allergies are on the standard consultation checklist [7], but they are captured verbally, so language matters. If a topical steroid is the suspect and you have an atopic history, say so specifically - that combination has a documented association in Korean patients [1].

References

  1. Choi YJ, et al. Analysis of Positive Patch Test Allergens in Allergic Contact Dermatitis Patients with Atopic Dermatitis. Annals of Dermatology, 2023;35(4):303-312. doi:10.5021/ad.23.001

  2. Choi WK, et al. Comparison of Patch Test Results Before and After Mask Use in Patients With Facial Dermatoses. Annals of Dermatology, 2024;36(6):389-391. doi:10.5021/ad.24.003

  3. Han Y, et al. Allergic Sensitization Pattern in the Korean Dermatologic Patients. Annals of Dermatology, 2022;34(6):431-441. doi:10.5021/ad.21.260

  4. Cheong SH, et al. Comparison of Marketed Cosmetic Products Constituents with the Antigens Included in Cosmetic-related Patch Test. Annals of Dermatology, 2010;22(3):262-268. doi:10.5021/ad.2010.22.3.262

  5. American Society for Dermatologic Surgery. Laser/Light Therapy. ASDS, accessed 11 November 2026.

  6. American Society for Dermatologic Surgery. Chemical Peels. ASDS, accessed 11 November 2026.

  7. American Society of Plastic Surgeons. Chemical Peel Consultation. ASPS, accessed 11 November 2026.

  8. Korea Tourism Organization and Korea Health Industry Development Institute. Registration System for Medical Institutions. Medical Korea, accessed 11 November 2026.

Related reading

About this guide. Korean Plastic Surgery Info is an independent information resource for international patients considering treatment in Korea. We do not own or operate clinics, we do not accept referral fees or commissions from providers, and no clinic pays to appear in our guides. Every figure above is taken from the cited source and was checked against that source on 11 November 2026. This article is general information, not medical advice, and it cannot substitute for assessment by a licensed physician who has examined your skin. Decisions about testing or treatment should be made with a doctor who can review your own history.

Comments


Exclusively Verified Lowest Price for Korean Plastic Surgery Clinics

(주)팀퍼포먼스 ㅣTeamperformance Co., Ltd.
대표자: 정용훈 ㅣRepresentative Director:  Yonghun Jung
사업자등록번호: 503-87-03152 ㅣBusiness Registration Number: 503-87-03152 

@copyright all reserved teamperformance

bottom of page